A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine a safe dose of XL844 in combination with
gemcitabine, how often it should be taken, and how well people with cancer tolerate the
combination of gemcitabine and XL844.